The trademark SATIVARIS was filed by Grupo HS3 Project Development S.L., a corporation established under the laws of the Kingdom of Spain (the "Applicant"). The application was published for oppositions on January 23, 2020, and received one opposition filed on May 15, 2020 by GW PHARMA LIMITED on (a) Likelihood of confusion, (b) Unfair advantage and detriment to distinctiveness or repute. the opponent was represented by JAK FRANCE and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued May 15, 2020
The application was filed in English, and English was also language of all opposition proceedings (German was selected as the second language).
A transfer of the trademark registration was recorded on March 15, 2023.